Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001853327-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | May 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
37,500
Total Value
$1,073,375.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | May 1, 2026 | Exercise/Conversion | 12,500 | $14.50 | $181,250.00 | 110,494 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | May 1, 2026 | Sale | 12,500 | $71.37 | $892,125.00 | 97,994 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | May 1, 2026 | Exercise/Conversion | 12,500 | $0.00 | $0.00 | 382,357 | Direct | โ | View Details |